Dupont Capital Management’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7,894
| Closed | -$630K | – | 2121 |
|
|
2021
Q1 | $630K | Sell |
7,894
-15,838
| -67% | -$1.24M | 0.02% | 818 |
|
|
2020
Q4 | $1.87M | Buy |
23,732
+8,009
| +51% | +$470K | 0.04% | 353 |
|
|
2020
Q3 | $691K | Buy |
15,723
+11,486
| +271% | +$566K | 0.02% | 626 |
|
|
2020
Q2 | $187K | Buy |
+4,237
| New | +$158K | ﹤0.01% | 1150 |
|
|
2018
Q4 | – | Sell |
-23,200
| Closed | -$2.14M | – | 1252 |
|
|
2018
Q3 | $2.14M | Buy |
+23,200
| New | +$2.21M | 0.05% | 366 |
|
|
2018
Q2 | – | Sell |
-3,502
| Closed | -$390K | – | 1059 |
|
|
2018
Q1 | $390K | Sell |
3,502
-9,618
| -73% | -$1.08M | 0.01% | 715 |
|
|
2017
Q4 | $1.35M | Buy |
13,120
+5,590
| +74% | +$557K | 0.03% | 449 |
|
|
2017
Q3 | $709K | Buy |
+7,530
| New | +$594K | 0.02% | 595 |
|
|
2017
Q2 | – | Sell |
-8,108
| Closed | -$649K | – | 1016 |
|
|
2017
Q1 | $649K | Sell |
8,108
-2,775
| -25% | -$221K | 0.01% | 626 |
|
|
2016
Q4 | $857K | Buy |
+10,883
| New | +$846K | 0.02% | 536 |
|
|
2016
Q3 | – | Sell |
-13,116
| Closed | -$901K | – | 723 |
|
|
2016
Q2 | $901K | Hold |
13,116
| – | – | 0.02% | 468 |
|
|
2016
Q1 | $936K | Buy |
13,116
+7,664
| +141% | +$481K | 0.02% | 461 |
|
|
2015
Q4 | $339K | Buy |
+5,452
| New | +$333K | 0.01% | 604 |
|
Dupont Capital Management's CMD Position: Q2 2021 in Review
Dupont Capital Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 7,894 shares — an estimated $630K sold.
Dupont Capital Management first reported a position in CMD in Q4 2015 and held it in 13 quarters. The position peaked at $2.14M in Q3 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Dupont Capital Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Dupont Capital Management sold 7,894 Cantel Medical Corporation shares in Q2 2021, an estimated $630K.
- Dupont Capital Management first reported a position in Cantel Medical Corporation in Q4 2015 and held it in 13 quarters.
- Dupont Capital Management's Cantel Medical Corporation position peaked at $2.14M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Dupont Capital Management's 13F filing for Q2 2021, filed 30 Jul 2021.